Saturn Virus
The Saturn virus, officially designated MRJ-1⁺, is a highly contagious, neurotropic RNA virus known for causing severe psychological and physiological effects in infected individuals. The virus is notable for its extremely low infectious dose, aggressive symptom progression, and near-100% fatality rate. It is named for the "ring" of behavioral and organ system disruptions that surround its core respiratory and neurological pathology.
Classification
- Virus group: Group IV ((+)ssRNA)
- Code name: MRJ-1⁺
- Genome: Single-stranded, positive-sense RNA (~13.6 kb)
- Family: Unclassified; exhibits traits similar to Flaviviridae and Rhabdoviridae
- Shape: Enveloped, spherical (90 nm diameter)
Virology
Saturn virus is a positive-sense single-stranded RNA virus that replicates in the cytoplasm of human host cells. It is enveloped with spike-like glycoproteins that bind to modified ACE2-like receptors, as well as an unidentified co-receptor believed to target neural tissue. The virus is extremely resilient in the environment, capable of surviving for extended periods on surfaces and in aerosols.
A unique feature of the Saturn virus is its dual targeting of the central nervous system and renal system, resulting in both severe neuropsychiatric effects and multi-organ failure.
Strains
| Strain Name | Code | Notes |
|---|---|---|
| YUO strain | YUO-777 | Most lethal strain; rapid onset of neurological symptoms and near-instant aggression in later stages. Fatality rate ~99.99%. Causes death within 72–96 hours. |
| NYE strain | NYE-959 | Most contagious strain; can spread via minimal contact or brief exposure. May remain airborne longer than other strains. Moderate fatality (~93%) but rapid outbreak potential. |
| KKT strain | KKT-999 | Balanced strain with both high lethality and moderate transmission. Common in urban cluster outbreaks. Often used as a reference strain in containment studies. |
| VNJ strain | VNJ-050 | Variant with delayed aggression symptoms; victims may appear normal longer, making identification difficult. Known for inducing paranoia and subtle stalking behaviors. |
| HCH strain | HCH-888 | Least contagious and least deadly. Mortality rate ~62%. Typically used for research under extreme biohazard precautions. Exhibits slower progression and muted behavioral effects. |
Transmission
The virus is extremely contagious, with an infectious dose of only 4 viral particles. It spreads through:
- Aerosol droplets (breathing, coughing)
- Fomite transmission (contaminated surfaces)
- Fecal-oral contact (vomit, diarrhea in later stages)
- Blood and bodily fluids in advanced infection
Infected individuals can transmit the virus even before showing symptoms.
Symptoms
Symptoms progress in distinct stages, beginning with common flu-like indicators and escalating into neurological and renal dysfunction. The full course of the disease typically lasts 4–5 days.
| Stage | Timeframe | Symptoms |
|---|---|---|
| Incubation | 0–12 hrs | No symptoms, but contagious |
| Early | 12–24 hrs | Fever, fatigue, headache, chills, sore throat |
| Intermediate | 24–48 hrs | Nausea, projectile vomiting, diarrhea, dry cough, fever above 103°F |
| Neurological | 48–72 hrs | Paranoia, auditory hallucinations, irritability, sensory sensitivity |
| Aggression phase | 72–96 hrs | Psychosis, violence, stalking behavior, self-muting |
| Terminal | 96–120 hrs | Renal failure, seizures, coma, death |
Behavioral Effects
One of the virus's defining traits is its aggression-inducing behavior in late-stage infection. Infected individuals become hyper-aware of sound and movement, often attacking others in silence. Survivors of early outbreaks report that silence and darkness are the only effective means of avoiding detection by late-stage carriers.
Infected persons may retain strategic thinking, motor skills, and hunting instincts while displaying extreme paranoia and violence.
Treatment and Containment
There is currently no known cure or effective treatment for Saturn virus. Standard antiviral agents are ineffective due to the virus's high mutation rate. Vaccination attempts have failed due to genetic instability of its envelope proteins.
Containment procedures include:
- Isolation in soundproof, dark rooms
- Use of full PPE and negative-pressure environments
- Immediate cremation or incineration of corpses
- Strict no-sound protocols during quarantine operations
Mortality and Prognosis
The Saturn virus has a case fatality rate of nearly 100%. No confirmed recoveries have been documented, and reinfection is presumed possible due to its rapid mutation. Death is typically due to multi-organ failure, with kidney collapse being the final common pathway.
Etymology
The name "Saturn virus" is derived from the mythological figure Saturn, associated with isolation, time, and destruction. The virus's behavioral symptoms—aggression, silence, and paranoia—evoke these themes. The scientific codename MRJ-1⁺ was assigned during early laboratory investigation but is not used in public reporting.